| The determination of ϵ-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometrie method using trinitrobenzenesulfonic acid WA Bubnis, CM Ofner III Analytical biochemistry 207 (1), 129-133, 1992 | 341 | 1992 |
| Chemical and swelling evaluations of amino group crosslinking in gelatin and modified gelatin matrices CM Ofner, III, WA Bubnis Pharmaceutical research 13, 1821-1827, 1996 | 234 | 1996 |
| Examination of self‐crosslinked gelatin as a hydrogel for controlled release MM Welz, CM Ofner III Journal of pharmaceutical sciences 81 (1), 85-90, 1992 | 143 | 1992 |
| Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin CR Cammarata, ME Hughes, CM Ofner III Molecular pharmaceutics 12 (3), 783-793, 2015 | 111 | 2015 |
| Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells RE Nicoletto, CM Ofner III Cancer Chemotherapy and Pharmacology 89 (3), 285-311, 2022 | 109 | 2022 |
| Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity CM Ofner III, YE Zhang, VC Jobeck, BJ Bowman Journal of pharmaceutical sciences 90 (1), 79-88, 2001 | 107 | 2001 |
| Swelling studies of gelatin I: gelatin without additives CM Ofner III, H Schott Journal of pharmaceutical sciences 75 (8), 790-796, 1986 | 75 | 1986 |
| Crosslinked gelatin matrices: release of a random coil macromolecular solute JW Mwangi, CM Ofner III International journal of pharmaceutics 278 (2), 319-327, 2004 | 70 | 2004 |
| Gels and jellies CM Ofner, CM Klech-Gelotte, J Swarbrick, JC Boylan Encyclopedia of pharmaceutical technology 2, 1327-1343, 2002 | 63 | 2002 |
| Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates CM Ofner III, K Pica, BJ Bowman, CS Chen International journal of pharmaceutics 308 (1-2), 90-99, 2006 | 48 | 2006 |
| Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables A Kosasih, BJ Bowman, RJ Wigent, CM Ofner III International journal of pharmaceutics 204 (1-2), 81-89, 2000 | 37 | 2000 |
| Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers DC Wu, CM Ofner AAPS PharmSciTech 14, 74-77, 2013 | 36 | 2013 |
| Gelatin-methotrexate conjugate microspheres as a potential drug delivery system K Pica, R Tchao, CM Ofner III Journal of pharmaceutical sciences 95 (9), 1896-1908, 2006 | 31 | 2006 |
| Swelling studies of gelatin II: Effect of additives CM Ofner III, H Schott Journal of pharmaceutical sciences 76 (9), 715-723, 1987 | 30 | 1987 |
| Colloidal dispersions BJ Bowman, CM Ofner, H Schott Remington: The Science and Practice of Pharmacy, 21st ed., Lippincott …, 2005 | 28 | 2005 |
| Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate DC Wu, CR Cammarata, HJ Park, BT Rhodes, CM Ofner Pharmaceutical research 30, 2087-2096, 2013 | 25 | 2013 |
| Microencapsulation of Chlorpheniramine Maleate–Resin Particles with Crosslinked Chitosan for Sustained Release RG Huang, JB Schwartz, CM Ofner Pharmaceutical development and technology 4 (1), 107-115, 1999 | 24 | 1999 |
| Shifts in the apparent ionization constant of the carboxylic acid groups of gelatin CM Ofner III, H Schott Journal of pharmaceutical sciences 74 (12), 1317-1321, 1985 | 21 | 1985 |
| Oral aqueous suspensions CM Ofner, RL Schnaare, JB Schwartz Pharmaceutical dosage forms: Disperse systems 2, 149-181, 1996 | 20 | 1996 |
| Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity BJ Bowman, CMIII Ofner Pharmaceutical research 17, 1309-1315, 2000 | 16 | 2000 |
